PKC Group Q4/2014: Strong cash flow, lower comparable

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PKC Group Q4/2014: Strong cash flow, lower comparable EBITDA and revenue

PKC Group Plc       Financial statement release   12 February 2015  8.15 a.m.

PKC Group Q4/2014:

Strong cash flow, lower comparable EBITDA and revenue

October - December 2014 highlights

  • Revenue decreased 1.7% on the comparison period (10-12/2013), totalling EUR 208.5 million (EUR 212.1 million).
  • EBITDA before non-recurring items was EUR 9.1 million (EUR 13.9 million) and 4.4% (6.6%) of revenue.
  • EBITA** was EUR 4.2 million (EUR 9.8 million) and 2.0% (4.6%) of revenue. During the report period PPA depreciation and amortisation totalled EUR 2.1 million (EUR 3.2 million).
  • Operating profit before non-recurring items was EUR 2.1 million (EUR 6.7 million) and 1.0% (3.1%) of revenue.
  • Earnings per share were EUR -0.63 including the impact of EUR -11.7 million non-recurring items in operating profit (EUR 0.08).
  • Cash flow after investments was EUR 30.7 million (EUR 18.5 million)

January – December 2014 highlights

  • Revenue decreased 6.2% on the comparison period (1-12/2013), totalling EUR 829.2 million (EUR 884.0 million).
  • EBITDA before non-recurring items was EUR 48.9 million (EUR 70.3 million) and 5.9% (8.0%) of revenue.
  • EBITA** was EUR 29.8 million (EUR 52.5 million) and 3.6% (5.9%) of revenue. During the financial year PPA depreciation and amortisation totalled EUR 8.2 million (EUR 11.6 million).
  • Operating profit before non-recurring items was EUR 21.7 million (EUR 40.9 million) and 2.6% (4.6%) of revenue.
  • Earnings per share were EUR -1.21 including the impact of EUR -28.4 million non-recurring items in operating profit and of EUR 8.3 million additional taxes (EUR 0.63).
  • Cash flow after investments was EUR 20.7 million (EUR 24.9 million).
  • Dividend proposal is EUR 0.70 per share (EUR 0.70 per share).

PKC Group’s outlook for 2015

  • PKC Group estimates that with prevailing exchange rates 2015 revenue will be close to previous year level, and that comparable EBITDA will be higher than in 2014. In 2014, PKC’s revenue was EUR 829.2 million and comparable EBITDA before non-recurring items was EUR 48.9 million. Revenue and EBITDA estimates are based on current business structure.
Key figures 10-12/14 10-12/13 Change % 1-12/14 1-12/13 Change %
EUR 1,000 (unless otherwise noted)        
Revenue 208,532 212,109 -1.7 829,219 883,986 -6.2
EBITDA* 9,137 13,946 -34.5 48,865 70,341 -30.5
% of revenue 4.4 6.6   5.9 8.0  
EBITA** 4,189 9,813 -57.3 29,833 52,461 -43.1
% of revenue 2.0 4.6   3.6 5.9  
Operating profit* 2,095 6,661 -68.5 21,677 40,873 -47.0
% of revenue 1.0 3.1   2.6 4.6  
Non-recurring items -11,739 -2,061 469.5 -28,362 -10,409 172.5
Operating profit(loss) -9,644 4,599 -309.7 -6,685 30,463 -121.9
% of revenue -4.6 2.2   -0.8 3.4  
Profit(loss) before taxes -11,160 1,942 -674.7 -10,528 21,562 -148.8
Net profit (loss) for the report period -14,992 1,783 -941.0 -29,051 13,947 -308.3
Earnings per share (EPS), EUR -0.63 0.08 -882.3 -1.21 0.63 -293.7
Cash flow after investments 30,737 18,513 66.0 20,699 24,941 -17.0
ROI,%       5.3 14.7  
Gearing, %       -5.6 -1.1  
Average number of personnel 20,165 18,946 6.4 19,640 19,206 2.3
* before non-recurring items  
** operating profit before PPA depreciation and amortisation and non-recurring items  
                 

Matti Hyytiäinen, President & CEO:

PKC’s revenue was EUR 829.2 million. PKC’s market position remained strong in all central product and geographical operating areas throughout the financial year. The number of trucks manufactured in Europe and Brazil fell short of the level of the previous year. Due to decreased production volumes, our revenue in Europe and Brazil fell. In North America, the production volumes of trucks exceeded the volumes of the previous year. Despite the positive truck market, PKC’s revenue in North America remained at the level of the previous year, as revenue was decreased by some product programmes of light vehicles and components reaching the end of their lifecycle. The revenue for PKC’s Electronics segment decreased in comparison to the previous year due to weakened demand in the EMS product area.

PKC’s operating profit before non–recurring items was EUR 21.7 million. The operating profit was unsatisfactory as a result of significant losses sustained in Brazil. Furthermore, investment in implementing strategy added the company’s expenses in the financial year.

Cash flows from operations was at the level of previous financial year, totalling EUR 41.0 million. The company is free of net liabilities, with gearing at -5.6%.

I want to warmly thank all PKC employees for the fact that once again we have succeeded in serving our customers in an excellent fashion. Several recognitions we have received during the financial year are a token of this.

In 2015, we expect the market environment to be fluctuating. The production of trucks in North America is forecast to grow from the level of 2014. On the other hand, we forecast the production of trucks in Europe to remain at the level of the previous year at most and the production in Brazil to decrease from the level of previous year. The demand for the products of PKC’s electronics segment is estimated to remain at the current level.

Market outlook

Wiring Systems Business

In 2015 the production of heavy-duty and medium-duty trucks in Europe is expected to remain on previous year’s level at the most.

Production of heavy-duty trucks in North America is expected to increase by about 14%, production of medium-duty trucks to decline by about 3% and production of light vehicles to increase by about 1% compared to 2014.

In 2015 the production of heavy-duty and medium-duty trucks in Brazil is expected to be lower than previous year. The governmental incentive program to support the purchase of new trucks continues to be valid until further notice, although the terms have been weakened significantly. The weakened terms and both economic and political uncertainty in Brazil bear a considerable risk for Brazilian truck sales for 2015.

Electronics Business

The market demand for Electronics segment’s products is expected to remain at the current level.

Disclosing procedures of financial reviews

PKC Group Plc follows the disclosure procedure enabled by Standard 5.2b published by the Finnish Financial Supervision Authority, and discloses relevant information related to its Interim Report with this release. PKC's financial statement release for January - December 2014 is attached to this release and is also available on company's website at www.pkcgroup.com.

PKC Group Plc

Board of Directors

Matti Hyytiäinen

President & CEO

For additional information, contact:

Matti Hyytiäinen, President & CEO, PKC Group Plc, tel. +358 (0)400 710 968

Juha Torniainen, CFO, PKC Group Plc, tel. +358 (0)40 570 8871

Press conference

A press conference on the financial statement will be arranged for analysts and investors today, 12 February 2015, at 10.00 a.m., at the address Event Arena Bank, Unioninkatu 20, Helsinki.

Attachment

PKC financial statement release 2014

Distribution

Nasdaq Helsinki

Main media

www.pkcgroup.com

PKC Group is a global partner, designing, manufacturing and integrating electrical distribution systems, electronics and related architecture components for the commercial vehicle industry and other selected segments. The Group has production facilities in Brazil, China, Estonia, Finland, Germany, Lithuania, Mexico, Poland, Russia, Serbia and the USA. The Group's revenue in 2014 totalled EUR 829.2 million. PKC Group Plc is listed on Nasdaq Helsinki.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 9

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Samer Alkhaldi Joins HFM to Drive Business Growth in MENA Region

Updated Category News Views 65

Samer Alkhaldi Takes Charge at HFM for MENA Development In an exciting development for HFM, a prominent player in global online trading, Samer Alkhaldi has been appointed as the new Regional Head of Business Development for the MENA region. With an extensive background in the financial sector, Samer’s appointment is a significant strategy to expand and improve services...

Continue Reading
Kenyan Government's Strategic Shift Towards Digital Operations

Updated Category News Views 286

Kenya's Digital Transformation with Danish F2 Platform The Kenyan government is embarking on an exciting journey towards digital transformation by adopting the Danish F2 platform. This innovative initiative was shared by the Ministry of Information, Communications, and the Digital Economy, aiming to streamline processes across various governmental departments. Objective...

Continue Reading
Brookfield Corporation Plans Upcoming Investor Day Event

Updated Category News Views 210

Brookfield Corporation's Investor Day Announcement Brookfield Corporation (NYSE: BN, TSX: BN) and Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) are gearing up for a significant Investor Day scheduled for a Wednesday in New York. This event aims to engage investors with insights on the company's strategic direction and performance metrics. Event Details The...

Continue Reading
Virtune Updates on MarketVector's Pricing Changes for ETPs

Updated Category News Views 155

Virtune Announces Important Pricing Update for ETPs Virtune, a leading player in digital asset management, has shared significant news regarding its approach to the pricing of its exchange-traded products (ETPs). Effective December 4, 2025, the company will update its reference price provider MarketVector, switching the underlying price source for its crypto assets used...

Continue Reading
Accessible Healthcare Support for Wildfire Affected Residents

Updated Category News Views 157

Virtual Healthcare Appointments for Affected Residents In light of the recent wildfires in Southern California, those who have faced displacement or adversity due to these events can now access more no-cost virtual healthcare appointments. This initiative is expanding to ensure that residents in Los Angeles can receive urgent medical attention, including vital services...

Continue Reading